Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Guardado en:

Detalles Bibliográficos
Autores principales:	Ahmed Al‑Darraji, Renée R. Donahue, Himi Tripathi, Hsuan Peng, Bryana M. Levitan, Lakshman Chelvarajan, Dalia Haydar, Erhe Gao, David Henson, John C. Gensel, David J. Feola, Vincent J. Venditto, Ahmed Abdel‑Latif
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/8bae5946a3c14d12a1ef4f74cf974221
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8bae5946a3c14d12a1ef4f74cf974221
record_format	dspace
spelling	oai:doaj.org-article:8bae5946a3c14d12a1ef4f74cf9742212021-12-02T17:05:12ZAuthor Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction10.1038/s41598-021-85720-62045-2322https://doaj.org/article/8bae5946a3c14d12a1ef4f74cf9742212021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85720-6https://doaj.org/toc/2045-2322An amendment to this paper has been published and can be accessed via a link at the top of the paper.Ahmed Al‑DarrajiRenée R. DonahueHimi TripathiHsuan PengBryana M. LevitanLakshman ChelvarajanDalia HaydarErhe GaoDavid HensonJohn C. GenselDavid J. FeolaVincent J. VendittoAhmed Abdel‑LatifNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ahmed Al‑Darraji Renée R. Donahue Himi Tripathi Hsuan Peng Bryana M. Levitan Lakshman Chelvarajan Dalia Haydar Erhe Gao David Henson John C. Gensel David J. Feola Vincent J. Venditto Ahmed Abdel‑Latif Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
description	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
format	article
author	Ahmed Al‑Darraji Renée R. Donahue Himi Tripathi Hsuan Peng Bryana M. Levitan Lakshman Chelvarajan Dalia Haydar Erhe Gao David Henson John C. Gensel David J. Feola Vincent J. Venditto Ahmed Abdel‑Latif
author_facet	Ahmed Al‑Darraji Renée R. Donahue Himi Tripathi Hsuan Peng Bryana M. Levitan Lakshman Chelvarajan Dalia Haydar Erhe Gao David Henson John C. Gensel David J. Feola Vincent J. Venditto Ahmed Abdel‑Latif
author_sort	Ahmed Al‑Darraji
title	Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
title_short	Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
title_full	Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
title_fullStr	Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
title_full_unstemmed	Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
title_sort	author correction: liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/8bae5946a3c14d12a1ef4f74cf974221
work_keys_str_mv	AT ahmedaldarraji authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT reneerdonahue authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT himitripathi authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT hsuanpeng authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT bryanamlevitan authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT lakshmanchelvarajan authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT daliahaydar authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT erhegao authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT davidhenson authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT johncgensel authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT davidjfeola authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT vincentjvenditto authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT ahmedabdellatif authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction
_version_	1718381802010181632

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction

Ejemplares similares